Table 5.
Univariate and multivariate analyses for DFS.
| Variable | Hazard ratio | 95% CI | P value |
|---|---|---|---|
| Univariate analysis | |||
| Age (≥65/<65) | 1.373 | 0.791-2.381 | 0.260 |
| Sex (male/female) | 0.826 | 0.467-1.461 | 0.512 |
| NRS 2002 scale(<3/≥3) | 0.672 | 0.163-2.763 | 0.582 |
| PG-SGA category(B/C) | 1.020 | 0.368-2.831 | 0.969 |
| PNI (≥45/<45) | 1.192 | 0.654-2.171 | 0.566 |
| PLR (≥162/<162) | 0.897 | 0.507-1.587 | 0.708 |
| NLR (≥2.5/<2.5) | 1.189 | 0.701-2.015 | 0.521 |
| Overall QOL(improved or stable/ decreased) | 0.465 | 0.198-1.093 | 0.079 |
| Treatment selection (LGJ/ES) | 5.109 | 2.827-9.233 | <0.001 |
| Multivariate analysis | |||
| Age (≥65/<65) | 1.149 | 0.635-2.077 | 0.646 |
| PNI (≥45/<45) | 1.174 | 0.639-2.156 | 0.605 |
| PLR (≥162/<162) | 0.746 | 0.393-1.419 | 0.372 |
| NLR (≥2.5/<2.5) | 1.212 | 0.694-2.116 | 0.500 |
| Overall QOL (improved or stable/ decreased) | 1.159 | 0.423-3.174 | 0.774 |
| Treatment selection (LGJ/ES) | 5.335 | 2.851-9.982 | <0.001 |
DFS, Disease-free survival; NRS 2002, Nutrition Risk Screening 2002; PG-SGA, Patient-Generated Subjective Global Assessment; PNI, Prognostic Nutritional Index; PLR, Platelet to lymphocyte ratio; NLR, Neutrophil to lymphocyte ratio; QOL, Quality of life.